An In vivo Wound Model Utilizing Bacteriophage Therapy of Pseudomonas aeruginosa Biofilms.
Bacteriophages have been used as effective therapy against bacterial biofilms on devices such as catheters, in the lungs such as in cystic fibrosis, and even in infected food. Unlike antibiotics, they are bacteria-specific and produce the desired effect without systemic complications; they can develop bacterial resistance, although in ways different from antibiotics. The present study aimed to assess the effect of bacteriophages against multidrug-resistant Pseudomonas aeruginosa in a mouse wound model. P. aeruginosa obtained from laboratory culture of burn wounds were characterized, harvested, and titrated, and biofilms were generated on sterile catheter sections (105 colony forming units/mL). Subcutaneous pockets were created on the backs of 24 male albino mice. Animals were randomized into 4 groups of 6 each. After evaluating a significant phage-bacteria interaction in vitro, 2 biofilm-laden catheter sections were implanted in subcutaneous pockets in mouse groups C and D. Sterile catheter sections only were implanted in group B. Group A had only a subcutaneous pocket without any catheter section. Phage cocktail solutions (10 \'b5L of 107 phage forming units/mL) were injected daily in group D pockets only. Groups B and C received 10 \'b5L of normal saline. After 10 days, the catheter sections were explanted from groups B, C, and D and tissue biopsy was taken from group A pockets and cultured for bacterial and phage colony counts. A significant drop in bacterial counts from 3.87 x 106 to 3.52 x 104 was observed in group D when compared with group C (3.87 x 106 to 3.85 x 105, P less than 0.05) A significant rise in the phage counts from 1 x 107 to 6.81 x 108 (P less than 0.05) also was observed in group D when compared with the baseline counts, indicating active phage proliferation and successful bacterial kill in group D. The present laboratory study could be indicative of a new treatment approach for multidrug-resistant bacterial infections, including wound infections.
The Departments of General Surgery and Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Somprakas
S
Basu
The Departments of General Surgery and Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Manav
M
Agarwal
The Departments of General Surgery and Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Satyanam
S
Kumar Bhartiya
The Departments of General Surgery and Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Gopal
G
Nath
The Departments of General Surgery and Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Vijay
V
Kumar Shukla
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001435:Bacteriophages / Q000276:immunology / Q000472:pathogenicity; D018441:Biofilms / Q000187:drug effects / Q000254:growth & development; D003430:Cross-Sectional Studies; D024881:Drug Resistance, Bacterial / Q000187:drug effects; D006801:Humans; D008297:Male; D051379:Mice; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D014945:Wound Healing / Q000187:drug effects
D000900:Anti-Bacterial Agents